N@N

CALP, ANF, DLLR, CPHD, GILD, FDP, Expected to Trade Lower After Bearish Insider Trading

^{Published on 2011-06-13 06:20:20 - WOPRAI}
 

June 13, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. CALIPER LIFE SCIENCES, INC. (NASDAQ:CALP), ABERCROMBIE & FITCH CO (NYSE:ANF), DOLLAR FINANCIAL CORP. (NASDAQ:DLLR), CEPHEID (NASDAQ:CPHD), GILEAD SCIENCES, INC. (NASDAQ:GILD), FRESH DEL MONTE PRODUCE INC (NYSE:FDP) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     CALP       CALIPER LIFE SCIENCES, INC.         Manyak, David M                     O           25,000         90                -20.6%                 12        
     ANF        ABERCROMBIE & FITCH CO              Jeffries, Michael S                 CEO         100,000        91                -8.9%                  56        
     DLLR       DOLLAR FINANCIAL CORP.              Weiss, Jeffrey A                    CEO         48,366         98                -10.0%                 29        
     CPHD       CEPHEID                             Persing, David H                    CT          70,000         92                -33.4%                 9         
     GILD       GILEAD SCIENCES, INC.               Metza-Anderson, M Kristen           O           5,500          94                -11.6%                 10        
     FDP        FRESH DEL MONTE PRODUCE INC         Abu, Ghazaleh Amir                  D           128,568        82                -10.5%                 14        

CALIPER LIFE SCIENCES, INC. (NASDAQ:CALP) - Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide. Its integrated systems consist of instruments, software and reagents, laboratory automation tools, and assay and discovery services. The company offers a portfolio of molecular imaging, microfluidics, automation and liquid handling technologies, and scientific applications to address various limitations in the drug discovery and development process. Its products include IVIS Imaging Systems and Living Image Software, an integrated optical molecular imaging solution; Light-Producing Cells and Microorganisms to analyze the spread and treatment of cancer and infectious diseases, as well as to study immunology; Light Producing Transgenic Animal models to analyze gene expression, protein activity, and disease progression; and luciferin, a chemical compound to produce bioluminescence, and VivoFluor fluorescent labeling kits for fluorescent imaging. The companys products also comprise LabChip GX series of instruments targeted at genomics applications; LabChip EZ Reader, EZ Reader II, and ProfilerPro Kits; Caliper Sciclone that incorporates automated microplate carriers; Zephyr, a liquid handling instrument; staccato automated workstations for drug discovery, genomics, proteomics, and drug development laboratories; Twister I and II, which automate the movement of microplates; TurboVap family of evaporators; and RapidTrace solid phase extraction workstation. In addition, it offers contract research services, drug discovery and development services, alliances and integrated research programs, environmental testing, and product support services. Caliper Life Sciences sells its products through direct sales force, a network of distributors, partnership channels, and joint marketing agreements. The company was founded in 1995 and is headquartered in Hopkinton, Massachusetts.

ABERCROMBIE & FITCH CO (NYSE:ANF) - Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer of casual apparel for men, women, and kids. The company sells casual sportswear apparel, including knit and woven shirts, graphic t-shirts, fleece, jeans and woven pants, shorts, sweaters, and outerwear; personal care products; and accessories under the Abercrombie & Fitch, abercrombie kids, and Hollister brands. It also offers bras, underwear, sleepwear, and at-home products for girls under the Gilly Hicks brand. The company sells products through its stores; direct-to-consumer operations; and Websites, which comprise abercrombie.com, abercrombiekids.com, hollisterco.com, and gillyhicks.com. As of January 29, 2011, it operated 1,069 stores in North America, Europe, and Japan. The company was founded in 1892 and is headquartered in New Albany, Ohio.

DOLLAR FINANCIAL CORP. (NASDAQ:DLLR) - Dollar Financial Corp. provides retail financial services to unbanked and under-banked consumers. It offers cash checking, single-payment consumer loans, longer-term installment loans, electronic tax filing, bill payment, foreign currency exchange, pawnbroking, debit cards and gift cards, photo ID, prepaid local and long-distance phone services, gold buying services, and legal document processing. The company provides its services through its stores, which operate under the names of Money Mart, The Money Shop, Loan Mart, Insta-Cheques, The Check Cashing Store, American Payday Loans, American Check Casher, Check Casher, Payday Loans, Cash Advance, Cash Advance USA, and We The People. As of June 30, 2009, it had a network of 1,206 stores, including 1,031 company-operated financial services stores and 175 franchised and agent locations in the United States, Canada, the United Kingdom, the Republic of Ireland, and Poland. The company, formerly known as DFG Holdings, Inc., was founded in 1990 and is headquartered in Berwyn, Pennsylvania.

CEPHEID (NASDAQ:CPHD) - Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical market, as well as for application in legacy biothreat, industrial, and partner markets. Its systems enable molecular testing for organisms and genetic-based diseases by automation. The company offers SmartCycler system that integrates DNA amplification and detection to allow rapid analysis of a sample; and GeneXpert system that integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for reference laboratories, hospital central laboratories, and satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors offices. It also provides GeneXpert Infinity System for high volume testing. The company offers tests for the GeneXpert and the SmartCycler systems in the areas of healthcare associated infections, critical infectious disease, genetics, womens health, and oncology. These tests include in vitro diagnostic medical devices, CE marked products, analyte specific reagents, and research use only tests. In the industrial market, it sells its SmartCycler system along with general use polymerase chain reaction reagents and reaction tubes. The company also offers tests for anthrax, pestis, and tullarensis in the biothreat market. Cepheid sells its products through direct sales and distribution channels worldwide. It has strategic commercial relationship with bioMerieux, Inc. for bioMerieux to develop DNA testing products using nucleic acid sequence-based amplification technology; and a collaboration agreement with Foundation for Innovative New Diagnostics for the development of a rapid molecular test for the measurement of human immunodeficiency virus viral load. The company was founded in 1996 and is based in Sunnyvale, California.

GILEAD SCIENCES, INC. (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The companys products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular age-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a Quad regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The companys Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Foster City, California.

FRESH DEL MONTE PRODUCE INC (NYSE:FDP) - Fresh Del Monte Produce Inc., together with its subsidiaries, produces, transports, sources, markets, and distributes fresh and fresh-cut fruit and vegetables worldwide. It also offers prepared fruit and vegetables, juices, beverages, and snacks. The company provides various fresh-cut fruit products, including pineapple, melons, grapes, citrus, apples, mango, pears, peaches, plums, nectarines, cherries, apricots, avocados, and kiwi; other fruit products comprising strawberries and plantains; and fresh-cut vegetable products primarily consisting of potatoes, onions, bell peppers, and cucumbers, as well as prepared salads, such as coleslaw and potato salad. In addition, Fresh Del engages in ocean freight; the manufacture of plastics and box products comprising bins, trays, bags, and boxes; growing grains on leased farms, including soybean, wheat, and rice; and the poultry farming businesses, as well as owns and operates grain silos for the storage of grains. The company markets and distributes its products to retail stores, foodservice operators, food clubs, wholesalers, and distributors. It offers its fresh produce under the DEL MONTE, UTC, and Rosy names; and prepared fruits and vegetables, juices, beverages, and snacks under the DEL MONTE, Fruit Express, Just Juice, and Fruitini names. The company was founded in 1886 and is based in George Town, Cayman Islands.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net